Amgen (AMGN) EBIT (2009 - 2026)
Amgen (AMGN) recorded EBIT of $3.51 billion in Q2 2026, up 32.3% from $2.66 billion a year earlier and up 31.8% from the prior quarter.
Powered by 
Analysis
Amgen (AMGN) EBIT (2009 - 2026) Analysis & Trends
On a TTM basis, Amgen's EBIT came in at $11.43 billion as of Jun 30, 2026, up 39.5% year-over-year; for FY2025, it came in at $9.08 billion, up 25.1% from FY2024.
- Annual EBIT has a five-year compound annual growth rate of -0.1% (FY2020 to FY2025).
- Across earlier years, EBIT came in at $7.26 billion in FY2024 (-8.1%), $7.9 billion in FY2023 (-17.4%), $9.57 billion in FY2022 (+25.2%) and $7.64 billion in FY2021 (-16.4%).
- The Q2 2026 figure is the highest quarterly EBIT in data going back to Q1 2009.
- On a year-over-year basis, EBIT has increased for eight consecutive quarters, with growth averaging 42.6% over the last eight quarters.
- Peak year-over-year performance for EBIT in the last five years was growth of 162.8% in Q2 2022, against a decline of 48.4% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.67 billion (Q1 2026), $2.72 billion (Q4 2025) and $2.53 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Vertex Pharmaceuticals | 128.38 Bn | 100.39 Bn | 2.84 Bn | 1.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.51 Bn |
| Mar 31, 2026 | 2.67 Bn |
| Dec 31, 2025 | 2.72 Bn |
| Sep 30, 2025 | 2.53 Bn |
| Jun 30, 2025 | 2.66 Bn |
| Mar 31, 2025 | 1.18 Bn |
| Dec 31, 2024 | 2.31 Bn |
| Sep 30, 2024 | 2.05 Bn |
| Jun 30, 2024 | 1.91 Bn |
| Mar 31, 2024 | 991.00 Mn |
| Dec 31, 2023 | 1.27 Bn |
| Sep 30, 2023 | 2.02 Bn |
| Jun 30, 2023 | 2.68 Bn |
| Mar 31, 2023 | 1.92 Bn |
| Dec 31, 2022 | 2.23 Bn |
| Sep 30, 2022 | 2.66 Bn |
| Jun 30, 2022 | 2.18 Bn |
| Mar 31, 2022 | 2.50 Bn |
| Dec 31, 2021 | 2.30 Bn |
| Sep 30, 2021 | 2.38 Bn |
API Access
Amgen EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=AMGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();